Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 5/2011

01-05-2011 | Case Report

Uncommon case of ankylosing spondylitis associated with spontaneous occurring hypoparathyroidism

Authors: Yousra Ibn Yacoub, Samira Rostom, Najia Hajjaj-Hassouni

Published in: Rheumatology International | Issue 5/2011

Login to get access

Abstract

Hypoparathyroidism and ankylosing spondylitis are two conditions with distinctive features which allow their differentiation. Hypoparathyroidism can be responsible for clinical and radiological changes resembling those seen in patients with ankylosing spondylitis. We report an exceptional case of a patient with an association between ankylosing spondylitis and a severe idiopathic hypoparathyroidism with difficulties in diagnosis. To our knowledge, this is the first case of such an occurrence.
Literature
1.
Gibberd FB (1965) Idiopathic hypoparathyroidism with unusual bone changes and spastic paraplegia. Acta Endocrinol (Copenh) 48:23–30
2.
Korkmaz C, Yaşar S, Binboğa A (2005) Hypoparathyroidism simulating ankylosing spondylitis. Joint Bone Spine 72(1):89–91PubMedCrossRef
3.
Adams JE, Davies M (1977) Paravertebral and peripheral ligamentous ossification: an unusual association of hypoparathyroidism. Postgrad Med J 53(617):167–172PubMedCrossRef
4.
Goswami R, Ray D, Sharma R, Tomar N, Gupta R, Gupta N, Sreenivas V (2008) Presence of spondyloarthropathy and its clinical profile in patients with hypoparathyroidism. Clin Endocrinol (Oxf) 68(2):258–263
5.
Jimenea CV, Frame B, Chaykin LB, Sigler JW (1971) Spondylitis of hypoparathyroidism. Clin Orthop Relat Res 74:84–89PubMedCrossRef
6.
Dougados M, VanderLinden S, Juhlin R, Huitfeldt B, Amor B, Calin A et al (1991) The European Spondylarthropathy Study Group: preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 34:1218–1227PubMedCrossRef
Metadata
Title
Uncommon case of ankylosing spondylitis associated with spontaneous occurring hypoparathyroidism
Authors
Yousra Ibn Yacoub
Samira Rostom
Najia Hajjaj-Hassouni
Publication date
01-05-2011
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 5/2011
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-009-1220-0

Other articles of this Issue 5/2011

Rheumatology International 5/2011 Go to the issue

Short Communication

Overlapping juvenile idiopathic arthritis and systemic lupus erythematosus: a case report

Original Article

Primary Raynaud phenomenon and small-fiber neuropathy: is there a connection? A pilot neurophysiologic study

Case Report

Digital ulcers as the first manifestation of carpal tunnel syndrome

Letter to the Editor

Invasive aspergillosis related with azathioprine-induced leucopenia without mutant allele of thioprine methyltransferase in a patient with rheumatoid arthritis

Original Article

Churg–Strauss syndrome: retrospective study in Burgundian population in France in past 10 years

Review

Role and therapeutic potential of Glycodelin A in systemic lupus erythematosus
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits